Final Evidence Report and Meeting Summary
Midwest CEPAC

PDF cover

Atopic Dermatitis: Final Report

Final Report and Meeting summary for ICER’s review of crisaborole and dupilumab for atopic dermatitis.

View

View All Materials on this Topic or Go Back to View More Materials